Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment. Feasibility and Acceptability Study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment.
研究概览
简要总结
Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.
详细描述
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment:
- Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient.
- Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS).
- Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in
- Criterion analysis of D-FOG
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 75 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 75 years and over
- •Carriers of diagnosed cancer (excluding hematology)
- •Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic)
- •Seen in nursing consultant
- •Beginning an oncological treatment
- •Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy
- •Patient not opposed to participate in the study
排除标准
- •Patients under 75 years of age
- •Having not had an IDE ad consultation
- •During oncological treatment
- •Receiving Oral Therapy or hormone therapy alone
- •Treated by radiotherapy alone or surgery alone
- •Not attending a day or week oncology hospital
- •Refusal to participate in research
结局指标
主要结局
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment.
时间窗: 3 months
Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG
次要结局
未报告次要终点